查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1825726

2025年内分泌胜肽检测全球市场报告

Endocrine Peptide Test Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年内分泌肽检测市场规模将强劲成长，到2029年将达到139亿美元，年复合成长率（CAGR）为8.7%。预测期内的增长归因于内分泌肽检测需求的不断增长、研发活动的不断增加、文明病的增多、老年人口的增长以及糖尿病在普通人群中的患病率的上升。预测期内的主要趋势包括内分泌检测方法的进步、产品技术的进步、新型检测解决方案研发活动的增加、产品核可数量的增加以及预防性医疗保健的转变。

未来五年8.7%的成长率预测，较我们先前对该市场的预测略有下降0.6%。这一下降主要源自于美国与其他国家之间关税的影响。预计关税壁垒将阻碍美国的发展，导致从德国和日本进口的内分泌肽检测套组成本上升，延误激素紊乱的诊断，并增加内分泌实验室的支出。由于互惠关税以及日益加剧的贸易紧张局势和限制对全球经济和贸易的负面影响，其影响也将更加广泛。

糖尿病盛行率的上升预计将推动内分泌肽检测市场的扩张。糖尿病是指一系列以血糖值升高为特征的疾病。糖尿病患者的增加归因于不良饮食、久坐不动的生活方式、遗传因素和人口老化等因素。内分泌肽测试，包括糖化血红蛋白、空腹血糖和 C 肽测试，用于诊断糖尿病、监测血糖浓度以及评估胰岛素的产生和敏感性。例如，2024 年 6 月，英国政府机构国家医疗服务体系 (NHS) 报告称，40 岁以下被诊断患有糖尿病的人数显着增加，从 2022 年的 173,166 人增加到 2023 年的 216,440 人。这一显着增长凸显了年轻一代糖尿病患病率上升的令人担忧的趋势。因此，糖尿病盛行率的上升正在推动内分泌肽检测市场的成长。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球内分泌肽测试：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球内分泌胜肽检测市场：成长率分析
  • 全球内分泌肽检测市场表现：规模与成长，2019-2024
  • 全球内分泌肽检测市场预测：规模与成长，2024-2029，2034
  • 全球内分泌胜肽检测：总目标市场（TAM）

第六章 市场细分

  • 全球内分泌肽检测市场（按检测类型、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 硫酸脱氢表雄酮
  • 孕酮
  • 黄体激素
  • 甲状腺催乳素
  • 雌二醇
  • 人类绒毛膜促性腺激素分泌
  • 甲状腺刺激素
  • 其他测试类型
  • 全球内分泌胜肽检测市场（依技术、效能和预测），2019-2024 年、2024-2029 年、2034 年
  • 质谱法
  • 免疫检测
  • 层析法
  • 基于核酸的
  • 其他技术
  • 全球内分泌肽检测市场（依最终用户、绩效及预测），2019-2024 年、2024-2029 年、2034 年
  • 诊所
  • 医疗保健中心
  • 医院
  • 商业研究所
  • 全球内分泌胜肽检测市场：按脱氢表雄酮硫酸盐 (DHEA-S) 细分，类型，性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 免疫检测
  • 酵素免疫分析法（ELISA）
  • 免疫检测（RIA）
  • 全球内分泌胜肽检测市场：依黄体素类型、表现及预测细分，2019-2024 年、2024-2029 年、2034 年
  • 免疫检测
  • 化学冷光分析
  • ELISA检测
  • 全球内分泌肽检测市场：黄体激素(LH) 细分，类型，性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 免疫检测
  • 酵素免疫分析法（EIA）
  • 免疫检测（RIA）
  • 全球内分泌胜肽检测市场：依甲状腺及催乳素类型细分、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 免疫检测
  • 化学冷光分析
  • 免疫检测（RIA）
  • 全球内分泌肽检测市场：按雌二醇类型、性能和预测细分，2019-2024 年、2024-2029 年、2034 年
  • 免疫检测
  • 酵素免疫分析法（ELISA）
  • 免疫检测（RIA）
  • 全球内分泌胜肽检测市场：按人类绒毛膜促性腺激素分泌(hCG) 细分，类型，性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 免疫检测
  • 化学冷光分析
  • 酵素免疫分析法（EIA）
  • 全球内分泌肽检测市场：甲状腺刺激素（TSH）细分市场，按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 免疫检测
  • 免疫检测（RIA）
  • 酵素免疫分析法（ELISA）
  • 全球内分泌肽检测市场：依其他检测类型细分（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 皮质醇
  • 胰岛素
  • 生长激素（GH）
  • 副甲状腺素（PTH）

第七章 区域和国家分析

  • 全球内分泌胜肽检测市场：依地区、绩效及预测，2019-2024、2024-2029、2034
  • 全球内分泌胜肽检测市场：依国家、绩效及预测，2019-2024、2024-2029、2034

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章：西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章：俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 内分泌胜肽检测市场：竞争格局
  • 内分泌胜肽检测市场：公司简介
    • Siemens AG Overview, Products and Services, Strategy and Financial Analysis
    • F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
    • Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Laboratory Corporation of America Holdings（LabCorp）
  • Quest Diagnostics Incorporated
  • Agilent Technologies Inc.
  • Illumina Inc.
  • bioMerieux SA
  • Bio-Rad Laboratories Inc.
  • DiaSorin SpA
  • Sciex
  • Bio-Techne Corporation
  • Invitae Corporation
  • ARUP Laboratories
  • Genova Diagnostics
  • Boston Heart Diagnostics Corporation
  • Immunodiagnostic Systems Ltd.
  • Mayo Clinic Laboratories

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029年内分泌胜肽检测市场：提供新机会的国家
  • 2029年内分泌肽检测市场：细分市场带来新机会
  • 2029年内分泌胜肽检测市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r30135u

The endocrine peptide test is a diagnostic procedure used to assess levels of specific peptides in blood or urine, crucial for monitoring the endocrine system's function and detecting related disorders. It primarily focuses on measuring peptide hormones in blood to diagnose and track endocrine disorders.

Key tests in the endocrine peptide market include dehydroepiandrosterone sulfate (DHEAS), progesterone, luteinizing hormone, thyroid prolactin, estradiol, human chorionic gonadotropin, thyroid-stimulating hormone, among others. The DHEAS test specifically measures DHEAS levels in the bloodstream. Technologies employed include mass spectroscopy, immunoassay, chromatography, nucleic acid-based methods, and others. End users include clinics, healthcare centers, hospitals, and commercial laboratories.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The endocrine peptide test market research report is one of a series of new reports from The Business Research Company that provides endocrine peptide test market statistics, including the endocrine peptide test industry global market size, regional shares, competitors with endocrine peptide test market share, detailed endocrine peptide test market segments, market trends, and opportunities, and any further data you may need to thrive in the endocrine peptide test industry. These endocrine peptide test market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The endocrine peptide test market size has grown strongly in recent years. It will grow from $9.11 billion in 2024 to $9.95 billion in 2025 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to increasing government spending, rising prevalence of diabetes, decreasing level of immunity in people across the world, high risk of contracting any chronic diseases, and rising government initiatives.

The endocrine peptide test market size is expected to see strong growth in the next few years. It will grow to $13.9 billion in 2029 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to increasing demand for endocrine peptide test, growth in research and development activities, rise in number of lifestyle diseases, increasing geriatric population, and rising prevalence of diabetes amongst the masses. Major trends in the forecast period include advancement in the endocrine testing method, advancements in product technologies, increasing research and development activities to develop novel testing solutions, growing number of product approval, and shift towards preventive healthcare.

The forecast of 8.7% growth over the next five years reflects a modest reduction of 0.6% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. by increasing the cost of endocrine peptide test kits sourced from Germany and Japan, thereby delaying hormone disorder diagnoses and elevating endocrinology lab expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growing prevalence of diabetes is expected to drive the expansion of the endocrine peptide test market. Diabetes refers to a range of conditions characterized by elevated blood sugar (glucose) levels. The rise in diabetes cases is attributed to factors such as poor diets, sedentary lifestyles, genetic factors, and an aging population. Endocrine peptide tests, including hemoglobin A1c, fasting plasma glucose, and C-peptide tests, are used to diagnose diabetes, monitor glucose levels, and evaluate insulin production and sensitivity. For example, in June 2024, the National Health Service (NHS), a UK-based government agency, reported a notable increase in the number of individuals under 40 diagnosed with diabetes, rising from 173,166 in 2022 to 216,440 in 2023. This significant increase highlights the concerning trend of rising diabetes cases among younger individuals. Therefore, the increasing prevalence of diabetes is fueling the growth of the endocrine peptide test market.

Leading companies in the endocrine peptide test market are advancing immunoassay testing systems to enhance accuracy, sensitivity, and speed. These systems employ antibodies to detect and quantify specific peptides in blood or urine samples, providing healthcare professionals with essential insights into hormone levels and endocrine function. For example, Siemens Healthineers introduced the Atellica CI Analyzer in July 2023, a compact system capable of immunoassay and clinical chemistry testing, including endocrine peptide assays. It features a reproductive endocrinology menu with tests such as anti-Mullerian hormone (AMH) for ovarian reserve assessment and sFlt-1 and PlGF for preeclampsia prognosis. With a capacity of up to 1000 tests per hour, the Atellica CI Analyzer ensures rapid and consistent delivery of high-quality results, supporting laboratories in meeting evolving testing demands.

In October 2022, Tolmar, a US-based pharmaceutical company, acquired Jatenzo from Clarus Therapeutics to bolster its portfolio in pediatric endocrinology and men's health. Jatenzo, a testosterone replacement therapy, complements Tolmar's specialty pharmaceutical products, enhancing their offerings for individuals with endocrine disorders. Clarus Therapeutics, known for developing therapies in this field, facilitated the acquisition, expanding Tolmar's market presence and therapeutic capabilities.

Major companies operating in the endocrine peptide test market are Siemens AG, F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Merck KGaA, Becton Dickinson and Company, Laboratory Corporation of America Holdings (LabCorp), Quest Diagnostics Incorporated, Agilent Technologies Inc., Illumina Inc., bioMerieux SA, Bio-Rad Laboratories Inc., DiaSorin S.p.A., Sciex, Bio-Techne Corporation, Invitae Corporation, ARUP Laboratories, Genova Diagnostics, Boston Heart Diagnostics Corporation, Immunodiagnostic Systems Ltd., Mayo Clinic Laboratories

North America was the largest region in the endocrine peptide test market in 2024. The regions covered in the endocrine peptide test market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the endocrine peptide test market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The endocrine peptide test market includes revenues earned by entities by providing services such as diagnostic testing, laboratory analysis, research studies, and clinical evaluations. The market value includes the value of related goods sold by the service provider or included within the service offering. The endocrine peptide test market also includes sales of diagnostic kits, reagents, testing instruments, and laboratory equipment. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Endocrine Peptide Test Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on endocrine peptide test market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for endocrine peptide test ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The endocrine peptide test market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Test-Type: Dehydroepiandrosterone Sulphate; Progesterone; Luteinizing Hormone; Thyroid Prolactin; Oestradiol; Human Chorionic Gonadotropin; Thyroid-Stimulating Hormone; Other Test-Types
  • 2) By Technology: Mass Spectroscopy; Immunoassay; Chromatography; Nucleic Acid Based; Other Technologies
  • 3) By End-User: Clinics; Healthcare Centers; Hospitals; Commercial Laboratories
  • Subsegments:
  • 1) By Dehydroepiandrosterone Sulphate (DHEA-S): Immunoassay Tests; Enzyme-Linked Immunosorbent Assay (ELISA); Radioimmunoassay (RIA)
  • 2) By Progesterone: Immunoassay Tests; Chemiluminescence Assays; ELISA Tests
  • 3) By Luteinizing Hormone (LH): Immunoassay Tests; Enzyme Immunoassay (EIA); Radioimmunoassay (RIA)
  • 4) By Thyroid Prolactin: Immunoassay Tests; Chemiluminescence Assays; Radioimmunoassay (RIA)
  • 5) By Oestradiol: Immunoassay Tests; Enzyme-Linked Immunosorbent Assay (ELISA); Radioimmunoassay (RIA)
  • 6) By Human Chorionic Gonadotropin (hCG): Immunoassay Tests; Chemiluminescence Assays; Enzyme Immunoassay (EIA)
  • 7) By Thyroid-Stimulating Hormone (TSH): Immunoassay Tests; Radioimmunoassay (RIA); Enzyme-Linked Immunosorbent Assay (ELISA)
  • 8) Other Test-Types: Cortisol; Insulin; Growth Hormone (GH); Parathyroid Hormone (PTH)
  • Companies Mentioned: Siemens AG; F. Hoffmann-La Roche AG; Thermo Fisher Scientific Inc.; Merck KGaA; Becton Dickinson and Company; Laboratory Corporation of America Holdings (LabCorp); Quest Diagnostics Incorporated; Agilent Technologies Inc.; Illumina Inc.; bioMerieux SA; Bio-Rad Laboratories Inc.; DiaSorin S.p.A.; Sciex; Bio-Techne Corporation; Invitae Corporation; ARUP Laboratories; Genova Diagnostics; Boston Heart Diagnostics Corporation; Immunodiagnostic Systems Ltd.; Mayo Clinic Laboratories
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Endocrine Peptide Test Market Characteristics

3. Endocrine Peptide Test Market Trends And Strategies

4. Endocrine Peptide Test Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Endocrine Peptide Test Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Endocrine Peptide Test PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Endocrine Peptide Test Market Growth Rate Analysis
  • 5.4. Global Endocrine Peptide Test Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Endocrine Peptide Test Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Endocrine Peptide Test Total Addressable Market (TAM)

6. Endocrine Peptide Test Market Segmentation

  • 6.1. Global Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Dehydroepiandrosterone Sulphate
  • Progesterone
  • Luteinizing Hormone
  • Thyroid Prolactin
  • Oestradiol
  • Human Chorionic Gonadotropin
  • Thyroid-Stimulating Hormone
  • Other Test-Types
  • 6.2. Global Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Mass Spectroscopy
  • Immunoassay
  • Chromatography
  • Nucleic Acid Based
  • Other Technologies
  • 6.3. Global Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Clinics
  • Healthcare Centers
  • Hospitals
  • Commercial Laboratories
  • 6.4. Global Endocrine Peptide Test Market, Sub-Segmentation Of Dehydroepiandrosterone Sulphate (DHEA-S), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Immunoassay Tests
  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Radioimmunoassay (RIA)
  • 6.5. Global Endocrine Peptide Test Market, Sub-Segmentation Of Progesterone, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Immunoassay Tests
  • Chemiluminescence Assays
  • ELISA Tests
  • 6.6. Global Endocrine Peptide Test Market, Sub-Segmentation Of Luteinizing Hormone (LH), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Immunoassay Tests
  • Enzyme Immunoassay (EIA)
  • Radioimmunoassay (RIA)
  • 6.7. Global Endocrine Peptide Test Market, Sub-Segmentation Of Thyroid Prolactin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Immunoassay Tests
  • Chemiluminescence Assays
  • Radioimmunoassay (RIA)
  • 6.8. Global Endocrine Peptide Test Market, Sub-Segmentation Of Oestradiol, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Immunoassay Tests
  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Radioimmunoassay (RIA)
  • 6.9. Global Endocrine Peptide Test Market, Sub-Segmentation Of Human Chorionic Gonadotropin (hCG), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Immunoassay Tests
  • Chemiluminescence Assays
  • Enzyme Immunoassay (EIA)
  • 6.10. Global Endocrine Peptide Test Market, Sub-Segmentation Of Thyroid-Stimulating Hormone (TSH), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Immunoassay Tests
  • Radioimmunoassay (RIA)
  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • 6.11. Global Endocrine Peptide Test Market, Sub-Segmentation Of Other Test-Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cortisol
  • Insulin
  • Growth Hormone (GH)
  • Parathyroid Hormone (PTH)

7. Endocrine Peptide Test Market Regional And Country Analysis

  • 7.1. Global Endocrine Peptide Test Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Endocrine Peptide Test Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Endocrine Peptide Test Market

  • 8.1. Asia-Pacific Endocrine Peptide Test Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Endocrine Peptide Test Market

  • 9.1. China Endocrine Peptide Test Market Overview
  • 9.2. China Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Endocrine Peptide Test Market

  • 10.1. India Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Endocrine Peptide Test Market

  • 11.1. Japan Endocrine Peptide Test Market Overview
  • 11.2. Japan Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Endocrine Peptide Test Market

  • 12.1. Australia Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Endocrine Peptide Test Market

  • 13.1. Indonesia Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Endocrine Peptide Test Market

  • 14.1. South Korea Endocrine Peptide Test Market Overview
  • 14.2. South Korea Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Endocrine Peptide Test Market

  • 15.1. Western Europe Endocrine Peptide Test Market Overview
  • 15.2. Western Europe Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Endocrine Peptide Test Market

  • 16.1. UK Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Endocrine Peptide Test Market

  • 17.1. Germany Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Endocrine Peptide Test Market

  • 18.1. France Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Endocrine Peptide Test Market

  • 19.1. Italy Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Endocrine Peptide Test Market

  • 20.1. Spain Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Endocrine Peptide Test Market

  • 21.1. Eastern Europe Endocrine Peptide Test Market Overview
  • 21.2. Eastern Europe Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Endocrine Peptide Test Market

  • 22.1. Russia Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Endocrine Peptide Test Market

  • 23.1. North America Endocrine Peptide Test Market Overview
  • 23.2. North America Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Endocrine Peptide Test Market

  • 24.1. USA Endocrine Peptide Test Market Overview
  • 24.2. USA Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Endocrine Peptide Test Market

  • 25.1. Canada Endocrine Peptide Test Market Overview
  • 25.2. Canada Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Endocrine Peptide Test Market

  • 26.1. South America Endocrine Peptide Test Market Overview
  • 26.2. South America Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Endocrine Peptide Test Market

  • 27.1. Brazil Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Endocrine Peptide Test Market

  • 28.1. Middle East Endocrine Peptide Test Market Overview
  • 28.2. Middle East Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Endocrine Peptide Test Market

  • 29.1. Africa Endocrine Peptide Test Market Overview
  • 29.2. Africa Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Endocrine Peptide Test Market Competitive Landscape And Company Profiles

  • 30.1. Endocrine Peptide Test Market Competitive Landscape
  • 30.2. Endocrine Peptide Test Market Company Profiles
    • 30.2.1. Siemens AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

31. Endocrine Peptide Test Market Other Major And Innovative Companies

  • 31.1. Laboratory Corporation of America Holdings (LabCorp)
  • 31.2. Quest Diagnostics Incorporated
  • 31.3. Agilent Technologies Inc.
  • 31.4. Illumina Inc.
  • 31.5. bioMerieux SA
  • 31.6. Bio-Rad Laboratories Inc.
  • 31.7. DiaSorin S.p.A.
  • 31.8. Sciex
  • 31.9. Bio-Techne Corporation
  • 31.10. Invitae Corporation
  • 31.11. ARUP Laboratories
  • 31.12. Genova Diagnostics
  • 31.13. Boston Heart Diagnostics Corporation
  • 31.14. Immunodiagnostic Systems Ltd.
  • 31.15. Mayo Clinic Laboratories

32. Global Endocrine Peptide Test Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Endocrine Peptide Test Market

34. Recent Developments In The Endocrine Peptide Test Market

35. Endocrine Peptide Test Market High Potential Countries, Segments and Strategies

  • 35.1 Endocrine Peptide Test Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Endocrine Peptide Test Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Endocrine Peptide Test Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer